Richard Malley MD
Associate Professor of Pediatrics, Boston Children's Hospital
Join to View Full Profile
300 Longwood AveChildren's Hospital Enders 861.3Boston, MA 02115
Phone+1 617-919-2900
Are you Dr. Malley?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Malley, MD is a pediatric infectious disease specialist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is an Associate Professor of Pediatrics at Boston Children's Hospital.
Education & Training
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1990 - 1993
Tufts University School of MedicineClass of 1990
Certifications & Licensure
MA State Medical License 1993 - 2025
American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 random...Dorota Borys, Ronald Smulders, Miwa Haranaka, Takashi Nakano, Gurunadh R Chichili
Vaccine. 2025-01-12 - 2 citationsSurface protein distribution in Group B Streptococcus isolates from South Africa and identifying vaccine targets through in silico analysis.Vicky Gent, Ying-Jie Lu, Sindiswa Lukhele, Nisha Dhar, Ziyaad Dangor
Scientific Reports. 2024-09-30 - Evaluation of a QuadrivalentSerotype 2a, 3a, 6, andO-Specific Polysaccharide and IpaB MAPS Vaccine.Emily M Boerth, Joyce Gong, Becky Roffler, Zoe Hancock, Lydia Berger
Vaccines. 2024-09-24
Authored Content
- A Vaccine That Stops Covid-19 Won’t Be EnoughAugust 2020
Press Mentions
COVID Is Spreading More Now Than in Any Previous Back-to-School Season. 3 Things Parents Can DoAugust 20th, 2024- Monkeypox Vaccine Available for Kids on Case-by-Case Basis, FDA SaysAugust 4th, 2022
- GSK to Buy Cambridge Vaccine Startup Affinivax for $2.1b, with More Payments PossibleMay 31st, 2022
- Join now to see all
